![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![AbbVie Header](https://www.pharmacompass.com/image/flap/abbvie-header-w29-desktop-header-1gif-4289.gif)
![AbbVie Header](https://www.pharmacompass.com/image/flap/abbvie-header-w29-mobgif-81230.gif)
X
20
Avon Lifesciences Limited Solapur In, based in India, is a pharmaceutical company.
One of their significant offerings is Pseudoephedrine hydrochloride, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2002-038 - Rev 02
This Chemical Type CEP, issued on January 28, 2016, remains in force until February 27, 2018, ensuring its reliability within the pharmaceutical industry.
Substance Number 1367 associated with this CEP further emphasizes